ENANTA PHARMACEUTICALS INC (ENTA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2011: $24.02M2012: $22.62M2013: $10.65M2016: $35.81M2017: $52.65M2018: $29.22M2019: $71.42M2020: $7.09M2021: -$70.00M2022: -$84.78M2023: -$103.15M2024: -$78.76M2025: -$19.27M-$19.27M
2011Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$19.27M+75.5%
2024-$78.76M+23.6%
2023-$103.15M-21.7%
2022-$84.78M-21.1%
2021-$70.00M-1087.5%
2020$7.09M-90.1%
2019$71.42M+144.4%
2018$29.22M-44.5%
2017$52.65M+47.0%
2016$35.81M
2013$10.65M-52.9%
2012$22.62M-5.8%
2011$24.02M